| 000 | 01787cam a2200313 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 008 | 140409s2013 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.19.M.Sc.2013.He.D | ||
| 100 | 0 | _aHeba Mosad Abdelaty Elbatal | |
| 245 | 1 | 0 |
_aDetection of vancomycin reduced susceptibility among methicillin-resistant staphylococcus aureus isolates using different susceptibility testing methods / _cHeba Mosad Abdelaty Elbatal ; supervised Mona Mahmoud Ezzat , Iman Ezzat Wali |
| 246 | 1 | 5 | _aالكشف عن السلالات المقاومة للفانكوميسين فى سلالات البكتيريا العنقودية المقاومة للميثيسيلين باستخدام اساليب اختيار نختلفة |
| 260 |
_aCairo : _bHeba Mosad Abdelaty Elbatal , _c2013 |
||
| 300 |
_a95 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Microbiology and Immunology | ||
| 520 | _aSince the emergence of methicillin-resistant staphylococcus aureus (MRSA), vancomycin has been the standard treatment for MRSA infections. The incidence reduced susceptibility to vancomycin is increasing in various parts of the world. The vast majority of clinical laboratories use disk diffusion method as the routine susceptibility testing which is not accurate in detection vancomycin's reduced susceptibility | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aMRSA | |
| 653 | 4 | _aReduced susceptibility | |
| 653 | 4 | _aVancomycin | |
| 700 | 0 |
_aIman Ezzat Wali , _eSupervisor |
|
| 700 | 0 |
_aMona Mahmoud Ezzat , _eSupervisor |
|
| 905 |
_aAml _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c45673 _d45673 |
||